1. DISORDERS OF CALCIUM METABOLISM
DR OGECHUKWU MBANU
FAMILY MEDICINE
DEPARTMENT
AKTH ,KANO
15TH DECEMBER 2017
2. Clinical scenrio 1
a 59 year old woman with a past medical history significant for
hypertension who comes for a routine clinic visit. She initially states
that she has no symptomatic complaints, but later in the interview
describes chronic fatigue and a mildly depressed mood. Her exam is
unremarkable. She used thiazide diuretics as treatment for
hypertension, Labs results showed:
Calcium (total) – 11.9 mg/dL (normal ~ 8.5-10.2 mg/dL)
Phosphate – 1.8 mg/dL (normal ~ 2.0-4.3 mg/dL)
Albumin – 3.8 g/dL (normal ~ 3.5-5.0 g/dL)
PTH – 124 pg/mL (normal ~ 10-60 pg/mL)
Creatinine – 1.2 mg/dL
3. Clinical scenario 2
• A 9-year-old boy presents to the emergency department with diffuse
abdominal pain, nausea, and vomiting 2 hours after sustaining blunt
trauma to the abdomen when he fell off his bike and hit the handlebars.
Laboratory studies show elevated amylase, lipase, and hypocalcemia. He
is diagnosed with acute pancreatitis and admitted for intravenous fluid
hydration and management. Which of the following findings is expected
to be seen as a result of the hypocalcemia?
• A. Decreased QT interval on electrocardiography
• B. Normal or slightly decreased phosphorus
• C. Positive Trousseau sign
• D. Rigidity of fingers (cannot be bent)
• E. Hypophosphatemia
4. OUTLINE
•Introduction
•Different forms of calcium
•Functions of calcium
•Calcium homeostasis
•Regulation of Ca metabolism
•Calcium metabolism disorders
•Conclusion
•References
5. INTRODUCTION
• Element number 20 in the periodic table
• Makes up 3% of the Earths crust
• Calcium ion: Ca2+ , Divalent cation
• Most Abundant Mineral In The Body
• Its about 1-2 kg ,of which 99% in bones and teeth , Rest of it is present in ECF
• Normal level of calcium is 9-11 mg/dl of blood
• Dietary sources includes Milk and milk products(good source) ,Boned fish,
green leafy veg , beans
• BODY REQUIREMENT
• Adult – 700 mg/day
• Children-1.2gm/day
• Pregnancy and lactation-1.5 gm/day
6. DIFFERENT FORMS OF CALCIUM
• Most of the calcium in the body exists as the mineral hydroxyapatite, Ca10(PO4)6(OH)2.
Calcium in the plasma:
• 45% in ionized form (the physiologically active form)
• 45% bound to proteins (predominantly albumin)
• 10% complexed with anions (citrate, sulfate, phosphate)
• Total calcium(usually measured in the lab): ionized calcium + protein bound + anion bound;
should be 2.2 to 2.6 mmol/L
• Corrected calcium: when the albumin is low, protein-bound calcium will also be low;
however the levels of ionized calcium remain unchanged
• Corrected calcium is what the total calcium WOULD BE if the patient had a normal albumin
level.
To estimate the physiologic levels of ionized calcium in states of hypoalbuminemia:
[Ca+2]Corrected = [Ca+2]Measured + [ 0.8 (4 – Albumin) ]
OR
corrected [Ca] in mmol/L = measured total [Ca] (mmol/L) + 0.02 x (40 – serum albumin in g/L)
7. DIFFERENT FORMS OF CALCIUM CONT’D
Normal Range of Total Serum Calcium
•8.5 to 10.5 mg/dl ( or 9-11 mg/dl of blood
•or 2.2-2.6 mmol/l (total)
Normal Range of Ionized Serum Calcium
• 1.17 to 1.33 mmol/l
•serum Phosphate (HPO4
2-):- 0.7-1.4 mmol/l
8. FUNCTIONS OF CALCIUM
• Muscle contraction - caused by Ca++ efflux from sarcoplasmic reticulum
• Neurotransmitter release - caused by Ca++ influx into presynaptic
terminal
• Conduction system of the heart - Uses Ca++ instead of Na+ to
depolarise
• Myocardial contraction - Ca++ influx is responsible for the plateau phase
of the action potential
• Clotting cascade - Ca++ is a cofactor required at most factor activation
steps, that’s why blood bank purple top tubes contain a calcium chelator
(EDTA)
• Bone integrity
• Cell signaling ,enzymatic co-factor
11. CALCIUM HOMEOSTASIS CONT’D RENAL
CALCIUM EXCRETION
• 10,000 mg Ca filtered through glomerulus per day
• Urinary calcium excretion is approx. 200 mg per day
• Only 2% of filtered Ca is normally excreted
12. CALCIUM HOMEOSTASIS CONT’D
CAUSES OF INCREASED CALCIUM ABSORPTION
• RENAL 1,25 –VIT D3 PRODUCTION
Growth
Pregnancy
Lactation
Primary hyperparathyroidism
Idiopathic hypercalciuria
• EXTRARENAL 1,25 VIT D3
Sarcoidosis
Granulomatous disorders e.g.
Tb,leprosy
B – cell lymphoma
Causes of decreased calcium absorption
• 1,25 –VITD3 PRODUCTION
Hypoparathyroidism
Vit. D deficiency
Vit. D deficiency rickets type 1
Chronic renal insufficiency
Aging
• NORMAL 1,25 –VIT D3
PRODUCTION
Glucocorticoid excess
Thyroid hormone excess
Intestinal malabsorption syndrome
Renal 1,25 – Vit d3 production
Low dietary Ca intake
13. REGULATION OF CALCIUM METABOLISM
Organ systems that play an import role in Ca2+ metabolism
Skeleton
GI tract
Kidney
CALCITROPIC HORMONES
Parathyroid hormone (PTH)
Calcitonin (CT)
Vitamin D (1,25 dihydroxycholecalciferol)
Parathyroid hormone related protein (PTHrP)
Calcium receptors:
•are present in the parathyroid gland, kidney , brain and other
organs
14. REGULATION OF CA METAB. CONT’D:- VITAMIN D
• Lipid soluble vitamin
• Precursors: - Cholecalciferol in the skin (produced by UV radioation) – Vitamin D3
• Ergocalciferol from diet – Vitamin D2
• Both get hydrolysed in the liver to 25-hydroxyvitamin D2
• Then, in the kidney, get hydrolysed again to 1,25-hydroxyvitamin D3(active form )
• Production in the kidney is catalyzed by 1 a-hydroxylase
• 1 A-HYDROXYLASE ACTIVITY IS INCREASED BY :
• serum Ca2+
• PTH level
• serum phosphate
VITAMIN D ACTIVITY:
• Increased gut absorption of calcium and phosphate
• Increased reabsorption of calcium and phosphate from the kidney
• Vitamin D increases Ca++ resorption from the bone
• Decreases hydroxylation of Vit D
16. REGULATION OF CA METAB. CONT’D:- CALCITONIN
•Produced by parafollicular(C) cells in the thyroid
gland
•Release stimulated by rising ionized calcium levels
•Action:
•directly inhibits osteoclast activity
•Increases renal excretion of calcium by inhibiting
resorption
•Calcitonin causes a decrease in plasma Ca++.
•Calcitonin is a physiological antagonist to PTH with
regard to Ca++ homeostasis
17. REGULATION OF CA METAB. CONT’D:- PARATHYROID HORMONE
• it is an 84-amino-acid hormone.
SECRETION:
• from the chief cells of the
parathyroid glands.
FUNCTION:- increase renal phosphate excretion , and increases
plasma calcium by:
osteoclastic resorption of bone (occurring rapidly).
Intestinal absorption of calcium (a slower response).
Synthesis of 1,25-(OH)2D3 (stimulating GIT absorption).
Renal tubular reabsorption of calcium
Serum phosphate
27. ETIOLOGY OF HYPERCALCEMIA
• T Thiazide,
other drugs - Lithium
•R Rhabdomyolysis
• A AIDS
• P Paget’s disease,
Parental nutrition,
Pheochromocytoma,
Parathyroid disease
Approx. 80% of all cases are caused by
Malignancy or Primary Hyperparathyroidism
V Vitamins
I Immobilization
T Thyrotoxicosis
A Addison’s disease
M Milk-alkali syndrome
I Inflammatory disorders
N Neoplastic related disease
S Sarcoidosis
29. • Neuromuscular
• Muscle weakness, hypotonia ,poor deep tendon reflex
• Cardiovascular
• Hypertension
• Short QT interval
• Skeletal
• Bone pain and tenderness
• Spontaneous fracture
• EYE(Band keratopathy)
• Corneal opacities
• Calcium deposition begins near the limbus at the 3 & 9
o’clock position
HYPERCALCEMIA: – CLINICAL SIGNS CONT’D
30.
31.
32. MANAGEMENT OF SEVERE HYPERCALCEMIA
• GOALS:
• Decrease bone resorption
• Increase calcium excretion
• Expand ECF volume
• Then, deal with the primary pathology, if possible
INDICATIONS FOR THERAPY
• Symptoms of hypercalcemia
• Plasma [Ca] >15 mg/dl
33.
34. HYPERPARATHYROIDISM
• Hyperparathyroidism is a metabolic disorder with excessive secretion of
Parathyroid hormone (PTH) above the normal level (12-70pg/mL)(2) ,
• HPT is characterized by
• ↑ PTH,
• PTH induced bone resorption
• Hhypercalcemia
• 3 Types
1. Primary HPT
2. Secondary HPT
3. Tertiary HPT
35. PRIMARY HYPERPARATHYROIDISM
•Excessive, relatively uncontrolled secretion of PTH
•One or more hyper functioning parathyroid glands.
•Hypercalcemia, the biochemical hallmark
•Most patients today are relatively asymptomatic.
•Symptoms remarkably varied and vague.
36. EPIDEMIOLOGY
• Incidence :0.1-0.3%. 1 case per 1000 men
• 2-3 cases per 1000 women.
•25/100000 population
•Incidence increases above age 40
•Most patients with sporadic primary
hyperparathyroidism are postmenopausal women with
an average age of 55 years
•Female to male ratio is 2-3:1
37. ETIOLOGY AND PATHOGENESIS
• Primary hyperparathyroidism is caused by
• Parathyroid adenoma – 80%
• Parathyroid hyperplasia – 15%
• Parathyroid carcinoma – 1-2%
• Approximately 10% are caused by “double adenoma”
• It can occur as part of at least three familial endocrinopathies
• MEN 1
• MEN 2A
• .Isolated familial hyperparathyroidism
39. LABORATORY FINDINGS
• Hypercalcemia is universal (>10.6 mg/dL)
• Serum phosphorus is low normal (<3.5 mg/dl) or low (<2.5 mg/dl)
• Mild hyperchloremic metabolic acidosis
• PTH is elevated or high normal
• Alkaline phosphatase
urine calcium
Serum chloride : phosphate ratio >33
Urinary ph
Serum chloride
40. MEDICAL MANAGEMENT PRIMARY HPT
•Estrogen
•Dose required is high
•SERMs (selective estrogen receptor modulators)
•Reduction in serum calcium and markers of bone turnover
after 4 weeks
•Bisphosphonates
•Studies have shown increase in lumbar spine and femoral
neck mineral density
•Calcium/Vitamin D
•Calcimimetic agents (Cinacalcet)
•Under investigation for primary HPT
41. SECONDARY HYPERPARATHYROIDISM
• the parathyroid glands are stimulated to produce increased amounts of
hormones to correct abnormally low serum calcium levels in different
• conditions like
renal failure,
Intestinal malabsorption syndrome
decrease of Vitamin D production
• this results in parathyroid hyperplasia
FINDINGS
• secretion of PTH
• Impaired absorption of Ca
• Impaired excretion of phosphates phosphates(renal cause)
• serum phosphate in other causes
• Impaired production of 1,25 –Vit D3
42. TERTIARY HYPERPARATHYROIDISM
• Tertiary When long-standing secondary hyperplasia becomes autonomous in
spite of correction of the underlying stimulant (renal transplant , dialysis)
• There is minimal Vit D production and little excretion of phosphates
FINDINGS
• increased gut absorption of Ca
• bone resorption of Ca
• Impaired excretion of phosphates phosphates
• Impaired production of 1,25-VitD3 but enough for absorption of Ca
43. HYPOPARATHYROIDISM
•Hypoparathyroidism is a metabolic disorder
characterized by low serum calcium and high serum
phosphate concentrations
• due to a deficiency or absence of PTH secretion
TYPES
1. Primary hypoparathyroidism
2. pseudohypoparathyroidism
44. TYPES OF HYPOPARATHYROIDISM
PRIMARY HYPOPARATHYROIDISM:-
• parathyroid gland is either
• not present
• or atrophied
• or do not function normally
• or damage to parathyroid gland after surgical excision (acquired hypoparathyroidism).
FINDINGS
serum PTH concentration
PSEUDOHYPOPARATHYROIDISM (PHP)
• parathyroid gland function is normal, but kidneys fail to respond to PTH due to
deficient receptor.
• As a result, the parathyroid glands secretes PTH in excess, and serum-PTH is
increased.
45. ETIOLOGY
•Some causes of hypoparathyroidism includes
Injury to or removal of the parathyroid glands
DiGeorge syndrome
Autoimmune diseases
Cancer radiation
Low magnesium levels
46. SIGNS AND SYMPTOMS
• Tingling or burning (paresthesias)
• Muscle aches or cramps
• Twitching or spasms of the muscles
• Fatigue or weakness
• Painful menstruation
• Patchy hair loss, such as thinning of your eyebrows
• Dry, coarse skin
• Brittle nails
• Headaches , seizures
• Depression, mood swings
• Memory problems
49. CONCLUSION
•Disorders of calcium metabolism can have devastating
effects on the health of patients and the well being of
the entire family
•A good understanding of calcium metabolism and
associated disorders is very important as there are
diverse causes affecting different age groups within
the family
•Early diagnosis and treatment are keys to good
management of this conditions and will help to control
symptoms and decrease the risk of other related
complex problems
50.
51. References
• Oral Manifestations of Parathyroid Disorders and Its Dental Management
Sanjeev Mittal, Deepak Gupta1 , Sahil Sekhri, Shivali Goyal. Department of
Prosthodontics, MM college of Dental Sciences and Research, Mullana, Ambala,
Haryana, 1 Department of Orthodontics, HS Judge Dental College, Panjab
University, Chandigarh, India.
• Primary Hyperparathyroidism Presented as Central Giant Cell Granuloma of Jaw
Bones. A Report of Three Cases Ibrahim Saeed Gataa1 BDS, FICMS Faraedon M.
Zardawi2* BDS, MSc, PhD
• Hyperparathyroidism-jaw tumour syndrome detected by aggressive generalized
osteitis fibrosa cystica Alae Guerrouani, Abdelkader Rzin, and Karim El Khatib
• Endocrine Physiology, 3rd ed. P.E. Molina; Chapter 5 (Via CIAP)
• Guyton & Hall Textbook of Medical physiology, 11th ed.; J.E.Hall; Chapter 79
• Oh’s Intensive Care Manual, 6th ed. B. Venkatesh; Chapter 54 Acute Calcium
Disorders
52. References
• Hypocalceamia presentation by Shaila Sukthankar
• Calcium metabolism and hypercalceamia presentation by alex yartsev
• Calcium metabolism and its disorders Dr Amir Babike MBBS, FRCPCH (UK), CCT
(UK), Msc in Endocrinology and Diabetes Queen Mary University, London(UK)
Consultant Paediatric Endocrinologist (KKUH) Assistant Professor (KSU, KSA)
• Disorders of Calcium Metabolism: Hypercalcemia Steven Chessler, MD,Ph.D. March, 2015 Internal
Medicine noon conference
• Disorders of Parathyroid Gland by Dr Irum siddiquie PGR Pediatrics
• Disorders of Parathyroid glands By: Garmyan YawarUniversity Of Sulaimani Faculty Of
Medical Sciences School Of Dentistry Oral Diagnosis Department
• Disorders of Parathyroid Gland Dr. Jeetendra K Singh
• PARATHYROID GLAND By: Steph and Lindsey
• Calcium metablolism presentation by Dr Krishnasamy
• Calcium homeostasis presentation by Dr Lederer